Neurology Ionis Young Investigator Grant (YIG)
The Neurology Ionis Young Investigator Grant funds early-career researchers pursuing innovative Angelman Syndrome research, supporting new scientific advances in neurology.
Funder: Ionis Pharmaceuticals
Due Dates (Anticipated): May 2027 (Application deadline, projected)
Funding Amounts: $50,000 per year for up to 2 years; second year contingent on progress; two awards annually
Summary: Supports early-career researchers conducting innovative research on Angelman Syndrome at academic or non-profit institutions.
Key Information: Forecasted opportunity—dates and details subject to change; check program page for updates.
Description
The Neurology Ionis Young Investigator Grant (YIG) is designed to foster the development of the next generation of clinicians and scientists focused on Angelman Syndrome. Established by the Ionis Neurology division, this annual program supports two early-career researchers—fellows, residents, or junior faculty—at academic or non-profit institutions. The grant encourages innovative translational, clinical, or applied research that advances the understanding, diagnosis, and care of Angelman Syndrome, aiming to improve patient outcomes and expand the field’s talent pipeline.
